Related Experiment Videos
[Various pulmonary lesions induced by high-pressure oxygen]
Minerva Medica
|May 12, 1976
Summary
Hyperbaric oxygen therapy can cause lung damage, including emphysema and inflammation. The severity of these pulmonary lesions in mice depends on the oxygen pressure and exposure duration.
Area of Science:
- Pulmonology
- Toxicology
- Pathology
Context:
- Hyperbaric oxygen therapy (HBOT) is a medical treatment that involves breathing pure oxygen in a pressurized chamber.
- While HBOT offers therapeutic benefits, it can also induce toxic effects on organs and tissues.
- Understanding oxygen toxicity mechanisms is crucial for safe HBOT application.
Purpose:
- To investigate the pulmonary lesions induced by hyperbaric oxygen in a mouse model.
- To determine the relationship between oxygen pressure, exposure time, and the observed pathological changes in the lungs.
- To elucidate the toxic action mechanisms of oxygen on lung tissue.
Summary:
- Mice exposed to varying hyperbaric oxygen pressures exhibited dose-dependent pulmonary lesions.
- Anatomopathological examinations revealed significant alterations, including emphysema, pulmonary edema, and extensive lung inflammation.
- These findings highlight the potential for hyperbaric oxygen to cause substantial lung injury.
Impact:
- Provides critical data on the dose-dependent pulmonary toxicity of hyperbaric oxygen.
- Informs the clinical application of HBOT by defining safe pressure and duration limits.
- Contributes to a better understanding of oxygen-induced lung injury mechanisms.